BRAF mutations occur in approximately 10% of CRC cases, with over 90% corresponding to the BRAF V600E variant, and are frequently associated with poor differentiation, advanced T stage, and an elevated risk of metastasis [30,31,63]. This evidence concerns the gene BRAF and colorectal carcinoma.